DANA HELGESON: Open Payments
NPI 1558994905 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 47 payments from 10 companies in 2025. Trend: 2023 $906 · 2024 $847 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $217 |
| GlaxoSmithKline, LLC. | 12 | $186 |
| AERIN MEDICAL INC. | 5 | $109 |
| Optinose US, Inc. | 5 | $81 |
| Medtronic, Inc. | 4 | $73 |
| Inspire Medical Systems, Inc. | 2 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: DUPIXENT, NUCALA, VIVAER STYLUS, Xhance, INSPIRE, NUVENT, NEFFY, PROPEL.
Industry payments across AZ — which companies pay providers there.
